Results 81 to 90 of about 2,408 (165)

The Role of Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Carcinoma in the Era of Emerging Systemic Therapy: A Retrospective Cohort Study. [PDF]

Cancers (Basel)
Ganiyani MA, Narvel H, Avudaiappan AP, Thiriveedi M, Raja Iyub MJ, Pustake M, Jatwani K, Manoharan M, Garje R.   +8 more
europepmc   +1 more source

The effect of cytoreductive nephrectomy on survival in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors. [PDF]

North Clin Istanb
Bilgetekin I, Ozturk E, Karacin C, Basal FB, Akdagcik Z, Oksuzoglu B.   +5 more
europepmc   +1 more source

Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy. [PDF]

J Urol, 2023
Reese SW, Khaleel S, Silagy A, Xie A, Eismann L, Vazquez-Rivera K, Oparanozie A, Patil S, Coleman J, Motzer R, Kotecha RR, Russo P, Voss MH, Hakimi AA.   +13 more
europepmc   +1 more source

Effect of Treatment Sequencing of Cytoreductive Nephrectomy on Overall Survival Outcomes in Patients Receiving Immunotherapy for Metastatic Renal Cell Carcinoma. [PDF]

Cureus
Zamani A, Cohn H, Moser AM, Michael Z, Krinock MJ, Fung G, Shao YF, Ginsburg KB.   +7 more
europepmc   +1 more source

The Prognostic Value of Clinical and Pathological Response to Neoadjuvant Therapy in Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Systematic Review and Clinical Implications. [PDF]

Cancers (Basel)
Chernysheva D, Hernandez-Peñalver P, Maroto P, Palou J, Breda A, Rodriguez-Faba O.   +5 more
europepmc   +1 more source

The role of delayed cytoreductive nephrectomy following axitinib-toripalimab for the mRCC patient in current immunotherapy era: a case report and literature review. [PDF]

Front Immunol
Zhou Q, Wang J, WenJing M, ZeLin Y, Yan J, Jin X.   +5 more
europepmc   +1 more source

Comparing Cytoreductive Nephrectomy with Tumor Thrombectomy Between Open, Laparoscopic, and Robotic Approaches. [PDF]

Cancers (Basel)
Sandberg M, Russell G, Krol P, Hayes M, Bissette R, Ben David R, Patel K, Aljabi B, Byun SS, Faba OR, Marchinena PG, Mourao T, Ciancio G, Peyton CC, Zanotti R, Spiess PE, Mehrazin R, Rais-Bahrami S, Abreu D, Zequi SC, Rodriguez AR.   +20 more
europepmc   +1 more source

Spontaneous regression of metastatic renal cancer and improvement in IMDC risk criteria prior to cytoreductive nephrectomy. [PDF]

Urol Case Rep, 2023
McGillivray K, McKenna R, Oades G, Rodger F.   +3 more
europepmc   +1 more source

A 73-Year-Old Man With a Late Isolated Brain Metastasis of Clear Cell Renal Cell Carcinoma Following a Durable Complete Response to Lenvatinib-Pembrolizumab, Resulting in Deferred Cytoreductive Nephrectomy. [PDF]

Am J Case Rep
Ito F, Kobayashi K, Hayashi G, Kamijo S, Fujita T.   +4 more
europepmc   +1 more source

Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study. [PDF]

Int J Urol
Nukaya T, Takahara K, Toyoda S, Inoki L, Fukuokaya W, Mori K, Iwata T, Bekku K, Maenosono R, Tsujino T, Hirasawa Y, Yanagisawa T, Hashimoto T, Komura K, Araki M, Fujita K, Ohno Y, Shiroki R.   +17 more
europepmc   +1 more source